These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22182249)

  • 1. Recent progress in computational approaches to studying the M2 proton channel and its implication to drug design against influenza viruses.
    Du QS; Huang RB
    Curr Protein Pept Sci; 2012 May; 13(3):205-10. PubMed ID: 22182249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in-depth analysis of the biological functional studies based on the NMR M2 channel structure of influenza A virus.
    Huang RB; Du QS; Wang CH; Chou KC
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1243-7. PubMed ID: 18996090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing inhibitors of M2 proton channel against H1N1 swine influenza virus.
    Du QS; Huang RB; Wang SQ; Chou KC
    PLoS One; 2010 Feb; 5(2):e9388. PubMed ID: 20186344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
    Gu RX; Liu LA; Wei DQ
    Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into adamantane-based M2 inhibitors with FB-QSAR.
    Wei H; Wang CH; Du QS; Meng J; Chou KC
    Med Chem; 2009 Jul; 5(4):305-17. PubMed ID: 19689387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
    Wang JF; Wei DQ; Chou KC
    Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in computational studies on influenza a virus M2 proton channel.
    Wang JF; Chou KC
    Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics.
    Watkins LC; DeGrado WF; Voth GA
    J Am Chem Soc; 2020 Oct; 142(41):17425-17433. PubMed ID: 32933245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Research/review: Structure and linkage disequilibrium analysis of adamantane resistant mutations in influenza virus m2 proton channel.
    Yu Y; Li X; Hao P; Wang JF; Chou KC
    Curr Drug Metab; 2014; 15(5):526-34. PubMed ID: 24909420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses.
    Wang J; Li F; Ma C
    Biopolymers; 2015 Jul; 104(4):291-309. PubMed ID: 25663018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetic analysis of the two controversial drug binding sites of the M2 proton channel in influenza A virus.
    Du QS; Huang RB; Wang CH; Li XM; Chou KC
    J Theor Biol; 2009 Jul; 259(1):159-64. PubMed ID: 19285514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics.
    Wang JF; Chou KC
    Protein Eng Des Sel; 2010 Aug; 23(8):663-6. PubMed ID: 20571121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine.
    Yi M; Cross TA; Zhou HX
    J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for proton conduction and inhibition by the influenza M2 protein.
    Hong M; DeGrado WF
    Protein Sci; 2012 Nov; 21(11):1620-33. PubMed ID: 23001990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel.
    Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S
    Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers.
    Sakai Y; Kawaguchi A; Nagata K; Hirokawa T
    Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
    Li F; Ma C; Hu Y; Wang Y; Wang J
    ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Broad-Spectrum Inhibitors of Influenza A Virus M2 Proton Channels: A Molecular Modeling Approach.
    Klimochkin YN; Shiryaev VA; Petrov PV; Radchenko EV; Palyulin VA; Zefirov NS
    Curr Comput Aided Drug Des; 2016; 12(2):154-64. PubMed ID: 27146707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.